Papillary carcinoma
Aug 21, 2023
Source: Cainiu Health
Dr. You Zhangxuan
Introduction
The causes of papillary carcinoma include genetic factors, age, lifestyle factors, estrogen and progesterone, gene mutations, etc. Treatment options are available.
I. Causes:
1. Genetic factors: Family history is associated with the development of papillary carcinoma, and there may be cases of close relatives having breast cancer or other related cancers.
Papillary carcinoma is associated with various causes including genetic factors, age, lifestyle factors, estrogen and progesterone exposure, and gene mutations; treatment options are also available. A detailed analysis is as follows:
I. Causes
1. Genetic factors: Family history is linked to the development of papillary carcinoma, particularly when close relatives have had breast cancer or other related cancers. Hereditary breast cancer syndromes can increase the risk of papillary carcinoma.
2. Age factors: The risk of breast cancer, including papillary carcinoma, increases with age. Papillary carcinoma is typically diagnosed after menopause, although it can also affect younger women and men.
3. Lifestyle factors: Certain environmental and lifestyle factors may contribute to the development of breast cancer, such as obesity, diet, alcohol consumption, physical inactivity, and smoking. These factors may increase the risk of papillary carcinoma by affecting hormone levels, immune function, or by generating carcinogenic substances.
4. Estrogen and progesterone: Changes in hormone levels may be associated with the development of breast cancer, including papillary carcinoma. Estrogen promotes cell proliferation in breast tissue, so prolonged exposure to high levels of estrogen may increase the risk of developing papillary carcinoma.
5. Gene mutations: Gene mutations play a significant role in the development of papillary carcinoma. Specific gene mutations can lead to abnormal cell proliferation and cancer formation. Examples include mutations in the BRCA1 and BRCA2 genes, which are associated with hereditary breast cancer.
II. Treatment Options
1. Surgical resection: Surgery is one of the primary treatments for papillary carcinoma. It typically involves removing the tumor along with surrounding normal tissue to ensure complete removal of cancer cells.
2. Radiation therapy: Radiotherapy is commonly used as an adjunctive treatment for papillary carcinoma. It uses high-energy radiation to kill cancer cells or inhibit their growth, helping to control or eliminate residual cancer cells. Radiation therapy may be administered before or after surgery to eradicate potential remaining cancer cells or prevent recurrence.
3. Chemotherapy: Chemotherapy uses drugs to kill or suppress the growth of cancer cells. For papillary carcinoma, chemotherapy is typically used in advanced cases, when lymph nodes are involved, or when distant metastases are present. Chemotherapeutic agents may be administered intravenously or orally and can be combined with other treatment modalities.
4. Targeted therapy: Targeted therapy involves using specific drugs to interfere with particular biological molecules or signaling pathways in cancer cells. For papillary carcinomas with specific genetic alterations or protein expression, such as HER2-positive breast cancer, targeted therapeutic agents may be used.
5. Hormone therapy: Certain subtypes of papillary carcinoma may be hormone-sensitive. Hormone therapy uses medications to block the effects of hormones in the body, thereby inhibiting the growth of cancer cells.
If you suspect you may have papillary carcinoma, it is recommended to seek medical evaluation promptly.
